# Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome

> **NCT00593658** · PHASE1 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 9 (actual)

## Conditions studied

- Hepatopulmonary Syndrome

## Interventions

- **DRUG:** pentoxifylline

## Key facts

- **NCT ID:** NCT00593658
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Poor tolerability of drug and side effects
- **Last updated:** 2015-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593658, "Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00593658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*